Literature DB >> 4647250

Vasopressin clearance and secretion during haemorrhage in normal dogs and in dogs with experimental diabetes insipidus.

M L Errington, M Rocha e Silva.   

Abstract

1. The secretion of vasopressin in response to haemorrhagic shock has been investigated in anaesthetized dogs.2. The changes in the plasma concentrations of vasopressin were followed over a period of 5 hr, during which the arterial blood pressure was kept constant at 40 mm Hg. It was found that vasopressin concentration in plasma rose to a high peak shortly after the onset of shock and gradually declined thereafter. Five hours later, it was still 3.5 times higher than control. Re-transfusion of blood was followed by a return to control levels.3. The clearance of vasopressin was calculated before and during shock in normal dogs and in dogs with experimental diabetes insipidus. Soon after the onset of shock, the clearance rate dropped to one quarter of its normal level but slowly recovered, returning to near control values at the fifth hour of shock. Clearance rates did not vary as a function of infusion rates, suggesting that there is no maximal transport rate for the removal of the hormone over the entire secretory range found in normal and hypotensive dogs.4. From the clearance rates and from the plasma concentrations of endogenously secreted vasopressin it has been possible to calculate the approximate secretory rates of the hormone in response to shock. Secretion rose to a very high level, some 40 times greater than control, at the onset of shock. This was followed by a fairly constant secretory plateau. At the fifth hour of shock secretion was 3.5 times higher than control.5. The half-life of vasopressin was measured in normal and hypotensive dogs. Control measurements confirm the generally accepted value of approximately 5 min. The half-life was significantly higher in the early stage of shock, but returned to control values in the later stage.6. Haemorrhage experiments performed in normal and diabetic dogs suggest that vasopressin may play a part in the development of irreversible haemorrhagic shock: all normal animals died within a few hours of retransfusion, whereas four out of eight diabetic dogs similarly treated survived a 24 hr observation period. In a separate set of experiments, eight diabetic dogs were subjected to the haemorrhage procedure while receiving a constant infusion of vasopressin: only two of these survived. Surviving dogs showed none of the characteristic lesions of irreversible haemorrhagic shock.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4647250      PMCID: PMC1331202          DOI: 10.1113/jphysiol.1972.sp010039

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  23 in total

1.  Clearance of exogenous vasopressin from plasma of dogs.

Authors:  H D LAUSON; M BOCANEGRA
Journal:  Am J Physiol       Date:  1961-03

2.  The intestinal factor in irreversible hemorrhagic shock.

Authors:  R C LILLEHEI
Journal:  Surgery       Date:  1957-12       Impact factor: 3.982

3.  Effect of anaesthetics and haemorrhage on the release of neurohypophysial antidiuretic hormone.

Authors:  L M BROWN; M GINSBURG
Journal:  Br J Pharmacol Chemother       Date:  1956-09

4.  Capacity of the neurohypophysis to release vasopressin.

Authors:  H Sachs; L Share; J Osinchak; A Carpi
Journal:  Endocrinology       Date:  1967-10       Impact factor: 4.736

5.  Intestinal vasoconstriction after hemorrhage: roles of vasopressin and angiotensin.

Authors:  J R McNeill; R D Stark; C V Greenway
Journal:  Am J Physiol       Date:  1970-11

Review 6.  Vascular smooth muscle. II. Pharmacology of normal and hypotensive vessels.

Authors:  A P Somlyo; A V Somlyo
Journal:  Pharmacol Rev       Date:  1970-06       Impact factor: 25.468

7.  A sensitive and specific assay for vasopressin in the circulating blood.

Authors:  N J Gilore; J R Vane
Journal:  Br J Pharmacol       Date:  1970-04       Impact factor: 8.739

8.  Antidiuretic hormone in cerebrospinal fluid during endogenous and exogenous changes in its blood level.

Authors:  H Vorherr; M W Bradbury; M Hoghoughi; C R Kleeman
Journal:  Endocrinology       Date:  1968-08       Impact factor: 4.736

Review 9.  Metabolism of antidiuretic hormones.

Authors:  H D Lauson
Journal:  Am J Med       Date:  1967-05       Impact factor: 4.965

10.  The release, clearance and plasma protein binding of oxytocin in the anaesthetized rat.

Authors:  M Fabian; M L Forsling; J J Jones; J Lee
Journal:  J Endocrinol       Date:  1969-02       Impact factor: 4.286

View more
  15 in total

Review 1.  [Treatment of hemorrhagic shock. New therapy options].

Authors:  W G Voelckel; A von Goedecke; D Fries; A C Krismer; V Wenzel; K H Lindner
Journal:  Anaesthesist       Date:  2004-12       Impact factor: 1.041

2.  Effect of Low-Dose Supplementation of Arginine Vasopressin on Need for Blood Product Transfusions in Patients With Trauma and Hemorrhagic Shock: A Randomized Clinical Trial.

Authors:  Carrie A Sims; Daniel Holena; Patrick Kim; Jose Pascual; Brian Smith; Neils Martin; Mark Seamon; Adam Shiroff; Shariq Raza; Lewis Kaplan; Elena Grill; Nicole Zimmerman; Christopher Mason; Benjamin Abella; Patrick Reilly
Journal:  JAMA Surg       Date:  2019-11-01       Impact factor: 14.766

3.  [Cytophysiology of secretion in the posterior pituitary gland of the rat. Ultrastructural study after stimulation in vivo].

Authors:  J L Boudier
Journal:  J Neural Transm       Date:  1974       Impact factor: 3.575

4.  Oxygen consumption in vitro by skin and urinary bladder of the euryhaline frog, Rana cancrivora.

Authors:  A B Elliott; C N Ong
Journal:  J Physiol       Date:  1973-08       Impact factor: 5.182

5.  Vasopressin secretion in response to haemorrhage: mathematical modelling of the factors involved.

Authors:  M Rocha e Silva; W Celso de Lima; E M Castro de Souza
Journal:  Pflugers Arch       Date:  1978-09-06       Impact factor: 3.657

6.  Vasopressin stimulates the proliferation and differentiation of red blood cell precursors and improves recovery from anemia.

Authors:  Balázs Mayer; Krisztián Németh; Miklós Krepuska; Vamsee D Myneni; Dragan Maric; John F Tisdale; Matthew M Hsieh; Naoya Uchida; Heon-Jin Lee; Michael J Nemeth; Kenn Holmbeck; Constance Tom Noguchi; Heather Rogers; Soumyadeep Dey; Arne Hansen; Jeffrey Hong; Ian Chow; Sharon Key; Ildikó Szalayova; Jerome Pagani; Károly Markó; Ian McClain-Caldwell; Lynn Vitale-Cross; W Scott Young; Michael J Brownstein; Éva Mezey
Journal:  Sci Transl Med       Date:  2017-11-29       Impact factor: 17.956

Review 7.  Management of vasodilatory shock: defining the role of arginine vasopressin.

Authors:  Martin W Dunser; Volker Wenzel; Andreas J Mayr; Walter R Hasibeder
Journal:  Drugs       Date:  2003       Impact factor: 9.546

8.  Interactions between vasopressin and glucagon on ketogenesis and oleate metabolism in isolated hepatocytes from fed rats.

Authors:  D H Williamson; V Ilic; A F Tordoff; E V Ellington
Journal:  Biochem J       Date:  1980-02-15       Impact factor: 3.857

9.  Mechanism for the 'anti-lipolytic' action of vasopressin in the starved rat.

Authors:  A M Rofe; D H Williamson
Journal:  Biochem J       Date:  1983-06-15       Impact factor: 3.857

10.  On the role of vasopressin and angiotensin in the development of irreversible haemorrhagic shock.

Authors:  M L Errington; M Rocha e Silva
Journal:  J Physiol       Date:  1974-10       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.